Medicamen Biotech consolidated net profit rises 59.50% in the March 2026 quarter

Sales rise 104.83% to Rs 60.65 crore

Net profit of Medicamen Biotech rose 59.50% to Rs 3.86 crore in the quarter ended March 2026 as against Rs 2.42 crore during the previous quarter ended March 2025. Sales rose 104.83% to Rs 60.65 crore in the quarter ended March 2026 as against Rs 29.61 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.58% to Rs 9.64 crore in the year ended March 2026 as against Rs 7.11 crore during the previous year ended March 2025. Sales rose 21.67% to Rs 197.77 crore in the year ended March 2026 as against Rs 162.55 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	60.65	29.61	105	197.77	162.55	22
OPM %	8.97	-5.44	-	9.91	8.53	-
PBDT	6.79	2.97	129	19.20	16.95	13
PBT	5.06	2.49	103	11.98	9.88	21
NP	3.86	2.42	60	9.64	7.11	36

Powered by Capital Market - Live News